Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.2 (Alpha)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Q.2 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.2 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BL.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BL.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
M.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
M.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
M.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.82 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.82 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.82 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.23.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.23.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.23.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.466.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.466.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.466.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.75.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBHNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBHNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BL.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BL.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.78NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.78NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.78NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used